Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

By HospiMedica International staff writers
Posted on 29 Sep 2026

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. More...

It is often missed until patients develop serious complications such as heart failure. Delayed diagnosis limits the opportunity to intervene before extensive cardiac damage occurs. Researchers have now developed an artificial intelligence platform that screens for the condition using images from electrocardiograms.

Yale School of Medicine (New Haven, CT, USA) scientists developed the AI to identify patients at risk for amyloid cardiomyopathy caused by misfolded transthyretin. The disease develops when transthyretin, a protein made in the liver, becomes misfolded because of genetics or age. Its accumulation stiffens the heart and impairs the electrical system that regulates heartbeat.

The platform analyzes images from electrocardiograms, which are non-invasive tests that measure the heart’s electrical activity. Physicians can access the tool from smartphones and use a photo of an electrocardiogram as the input. The model is designed to detect subtle electrocardiographic patterns associated with cardiac amyloid risk.

Researchers in the Yale Cardiovascular Data Science Lab first trained an AI model to interpret electrocardiogram results using data from thousands of de-identified patients. They then used several hundred patients in the dataset who already had amyloid cardiomyopathy to build a model that could recognize disease-associated patterns. In the study, the team tested the model across eight distinct patient cohorts in the United States and Europe.

The platform successfully identified individuals with transthyretin amyloid cardiomyopathy in those cohorts. The work was described recently in JAMA. The tool has received U.S. Food and Drug Administration (FDA) Device Designation through the Breakthrough Devices Program and is currently under FDA review. Scientists are also studying implementation of related multimodal artificial intelligence tools in the TRACE-AI Network Study, an observational study at 13 U.S. health centers.

“We are able to leverage just an image from a very simple ECG into a screening test for cardiac amyloid. For a disease that’s massively underdiagnosed, identifying those at risk is very critical,” said Rohan Khera, MD, director of the Cardiovascular Data Science Lab at Yale School of Medicine and the study’s principal investigator. 

“Our tool can really narrow down the funnel for who should be further evaluated for cardiac amyloid,” added Philip Croon, MMed, associate research scientist at Yale School of Medicine and the first author of the study.

Related Links
Yale School of Medicine


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.